Table 3.
Univariate (Model 1) and multivariate (Model 2) inverse probability to treatment weighted regression models for afewer hospital-free days at 30, 90 and 180 days
| 30-Day Hospital-Free Days | 90-Day Hospital Free Days | 180-Day Hospital Free Days | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | ||||
| Model 1 | ||||||||||||
| Treatment | ||||||||||||
| Medical (ref) | ||||||||||||
| Surgery | 3.98 | 3.40 | 4.67 | < 0.0001 | 1.24 | 1.08 | 1.42 | 0.004 | 0.89 | 0.77 | 1.02 | 0.09 |
| Model 2 | ||||||||||||
| Treatment | ||||||||||||
| Medical (ref) | ||||||||||||
| Surgery | 4.54 | 3.86 | 5.34 | < 0.0001 | 1.26 | 1.09 | 1.46 | 0.002 | 0.87 | 0.75 | 1.01 | 0.06 |
| Age | 1.00 | 0.99 | 1.01 | 0.97 | 1.00 | 1.00 | 1.01 | 0.65 | 1.01 | 1.00 | 1.01 | 0.08 |
| Gender | ||||||||||||
| Female (ref) | ||||||||||||
| Male | 1.07 | 0.90 | 1.28 | 0.45 | 1.09 | 0.93 | 1.29 | 0.30 | 1.14 | 0.97 | 1.34 | 0.13 |
| Race/Ethnicity | ||||||||||||
| Caucasian (ref) | ||||||||||||
| Asian/Pacific Islander | 0.94 | 0.73 | 1.21 | 0.64 | 1.01 | 0.80 | 1.27 | 0.94 | 1.05 | 0.83 | 1.32 | 0.69 |
| Black | 1.90 | 1.44 | 2.49 | < 0.0001 | 1.37 | 1.03 | 1.84 | 0.03 | 1.22 | 0.91 | 1.62 | 0.18 |
| Hispanic | 0.92 | 0.73 | 1.17 | 0.51 | 1.07 | 0.86 | 1.34 | 0.53 | 1.13 | 0.91 | 1.40 | 0.28 |
| Other/Unknown | 1.13 | 0.67 | 1.91 | 0.66 | 0.90 | 0.56 | 1.43 | 0.65 | 0.70 | 0.45 | 1.09 | 0.11 |
| Elixhauser Comorbidity | 1.06 | 1.05 | 1.07 | < 0.0001 | 1.04 | 1.03 | 1.05 | < 0.0001 | 1.04 | 1.03 | 1.05 | < 0.0001 |
| DNR Status | 1.95 | 1.50 | 2.54 | < 0.0001 | 2.37 | 1.82 | 3.07 | < 0.0001 | 2.60 | 1.99 | 3.38 | < 0.0001 |
| Ascites | 2.04 | 1.62 | 2.56 | < 0.0001 | 2.38 | 1.91 | 2.97 | < 0.0001 | 2.19 | 1.75 | 2.75 | < 0.0001 |
| Cancer Diagnosis | ||||||||||||
| Colorectal (ref) | ||||||||||||
| Ovarian | 0.79 | 0.61 | 1.04 | 0.09 | 0.71 | 0.55 | 0.92 | 0.01 | 0.76 | 0.59 | 0.99 | 0.04 |
| Pancreatic | 1.37 | 0.89 | 2.12 | 0.16 | 1.65 | 1.09 | 2.50 | 0.02 | 2.24 | 1.48 | 3.39 | 0.0001 |
| Hepatobiliary | 1.02 | 0.42 | 2.46 | 0.97 | 1.86 | 0.79 | 4.40 | 0.16 | 1.66 | 0.80 | 3.44 | 0.17 |
| Foregut & Small Bowel | 1.03 | 0.65 | 1.62 | 0.91 | 1.46 | 0.96 | 2.22 | 0.07 | 2.23 | 1.48 | 3.35 | 0.0001 |
| Nonovarian Urogyn | 1.37 | 1.00 | 1.87 | 0.05 | 1.63 | 1.21 | 2.19 | 0.001 | 1.90 | 1.11 | 3.25 | 0.02 |
| Lung/Mediastinal | 0.93 | 0.51 | 1.70 | 0.81 | 1.27 | 0.74 | 2.17 | 0.38 | 2.11 | 1.56 | 2.88 | < 0.0001 |
| Other | 0.97 | 0.69 | 1.36 | 0.84 | 0.75 | 0.55 | 1.03 | 0.07 | 1.06 | 0.77 | 1.45 | 0.73 |
| Unknown | 0.82 | 0.65 | 1.04 | 0.10 | 0.84 | 0.67 | 1.05 | 0.12 | 0.91 | 0.73 | 1.14 | 0.41 |
| Multiple Diagnoses | 0.99 | 0.77 | 1.27 | 0.95 | 1.22 | 0.96 | 1.54 | 0.10 | 1.29 | 1.02 | 1.63 | 0.04 |
CI confidence interval, Ref reference, Urogyn urogynecological, afewer HFDs defined as below the median HFD for each respective time interval (< 20 days for 30-day HFDs, < 70 days for 90-day HFDs, and < 133 for 180-day HFDs)